95.20
0.00
(0.00%)
At close: January 10 at 8:00:46 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
15,973,000.00
14,458,000.00
14,236,000.00
15,071,000.00
13,650,000.00
Investing Cash Flow
-6,240,000.00
5,596,000.00
1,468,000.00
4,208,000.00
-13,182,000.00
Financing Cash Flow
-9,353,000.00
-14,278,000.00
-20,562,000.00
-16,264,000.00
-2,208,000.00
End Cash Position
13,433,000.00
13,393,000.00
7,517,000.00
12,407,000.00
9,658,000.00
Capital Expenditure
-3,466,000.00
-2,753,000.00
-2,239,000.00
-2,556,000.00
-2,585,000.00
Issuance of Debt
--
546,000.00
252,000.00
16,000.00
9,387,000.00
Repayment of Debt
-2,565,000.00
-2,481,000.00
-2,837,000.00
-5,987,000.00
-2,315,000.00
Repurchase of Capital Stock
-6,820,000.00
-8,719,000.00
-10,652,000.00
-3,057,000.00
-2,842,000.00
Free Cash Flow
12,507,000.00
11,705,000.00
11,997,000.00
12,515,000.00
11,065,000.00
12/31/2020 - 3/7/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RHO6.F Roche Holding AG
35.15
-0.51%
JNJ.DE Johnson & Johnson
139.68
+1.13%
1BAYN.MI Bayer Aktiengesellschaft
19.99
+1.38%
PFE.DE Pfizer Inc.
26.37
+1.15%
LLY.F Eli Lilly and Company
774.00
+1.08%
NOV.DE Novo Nordisk A/S
84.60
-0.31%
AZN.L AstraZeneca PLC
10,982.00
-0.05%
GSK.L GSK plc
1,349.50
0.00%
BAYN.DE Bayer Aktiengesellschaft
19.98
+1.13%
ROG.SW Roche Holding AG
267.20
-1.69%